EPISODE · Sep 21, 2021 · 1H 3M
Podcast Extra - Abortion and the Covid-19 Vaccines w/ Dave Brennan of Brephos
from Irreverend: Faith and Current Affairs · host J.A. Franklin, T.J. Pelham, Daniel French
In this special episode, Rev Jamie Franklin sits down with Director of Brephos Ministries, Dave Brennan. Brephos is a ministry that helps Christians and churches to think through the issue of abortion and related challenges. In this conversation, Jamie and Dave discuss the Covid-19 vaccines specifically with regards to the use of human embryonic tissue in their development and testing. What has the Church's response been to the fact of the use of this aborted foetal tissue? How should a Christian respond to these facts? And what can the current response tell us about the spiritual health of the Church and our nation? For Dave's ministry, please see: https://www.brephos.orgNotices:Thanks to our Patreons! Support us from £1.50 plus VAT per month: https://patreon.com/irreverendIrreverend Weekly Sermon Audio: https://irreverendsermonaudio.buzzsprout.comTwitter: https://twitter.com/IrreverendPodTelegram: https://t.me/irreverendpodEmail: [email protected] YouTube: https://www.youtube.com/channel/UCMAcRZPstCujEN4p8dF_ClQOdysee: https://odysee.com/@irreverend:5Audio Podcast: https://irreverend.buzzsprout.comSupport the show
What this episode covers
In this special episode, Rev Jamie Franklin sits down with Director of Brephos Ministries, Dave Brennan. Brephos is a ministry that helps Christians and churches to think through the issue of abortion and related challenges. In this conversation, Jamie and Dave discuss the Covid-19 vaccines specifically with regards to the use of human embryonic tissue in their development and testing. What has the Church's response been to the fact of the use of this aborted foetal tissue? How should a Chris...
NOW PLAYING
Podcast Extra - Abortion and the Covid-19 Vaccines w/ Dave Brennan of Brephos
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m